19.05.2020
- Anglo-Swedish drugmaker AstraZeneca has announced it will make as many as 30 million initial doses of a potential Covid-19 vaccine available by September this year, assuming the...
27.03.2020
- Anglo-Swedish drugmaker AstraZeneca has announced plans to collaborate with UK biotech Silence Therapeutics to discover, develop and commercialize small interfering RNA (siRNA)...
29.01.2020
- Anglo-Swedish drugmaker AstraZeneca plans to invest up to $1 billion in a scheme it calls Ambition Zero Carbon, which as the name suggests is aimed at achieving zero carbon...
06.12.2019
- The chemical, pharmaceutical and life sciences industries in Switzerland — organized in the Scienceindustries trade association — account for 45% of total exports with around 70...
14.11.2019
- Major drugmaker AstraZeneca has announced plans to launch three initiatives in China to advance global R&D efforts. The plans include establishing global R&D and artificial...
11.06.2019
- North America should continue to lead global pharmaceutical sales up to 2022, with $635 billion in revenue expected that year, drugmaker AstraZeneca said in a recently published...
08.05.2019
- Anglo-Swedish drugmaker AstraZeneca is to collaborate with French biotech Transgene, part of Institut Mérieux, to discover and develop immunotherapies for treating cancers and...
03.04.2019
- In a move to accelerate the development of its oncology franchise, AstraZeneca has agreed a $6.9 billion deal with Japanese pharma major Daiichi Sankyo to share rights to a new...
